Publikationer

Her kan du finde en oversigt over publikationer fra medlemmer af REPAIRkuben.

  • Issa II, Due H, Brøndum RF, Veeravakaran V, Haraldsdóttir H, Sylvester C, Brogaard A, Dhanjal S, Schmierer B, Dybkær K. CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers (Basel). 2024 Jul 2;16(13):2437. doi: 10.3390/cancers16132437. PMID: 39001501

  • Bentestuen M, Ladekarl M, Knudsen A, Zacho HD. Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. BMC Cancer. 2024 Jun 7;24(1):699. doi: 10.1186/s12885-024-12461-w. PMID: 38849741

  • Terp SK, Pedersen IS, Stoico MP. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality. J Mol Diagn. 2024 Apr;26(4):310-319. doi: 10.1016/j.jmoldx.2024.01.008. Epub 2024 Feb 2. PMID: 38336350

  • Mark LR, Terp SK, Krarup HB, Thomassen M, Pedersen IS, Bøgsted M. Homologous Recombination Deficiency Detection Algorithms: A Systematic Review. Cancers. 2023 nov. 29;15(23):5633. PMID:38067337

  • Ladekarl, M., Nøhr, A. K., Sønderkær, M., Dahl, S. C., Sunde, L., Vestereghem, C., Mapendano, C. K., Haslund, C. A., Pagh, A., Carus, A., Lörincz, T., Nowicka-Matus, K., Poulsen, L. Ø., Laursen, R. J., Dybkær, K., Poulsen, B. K., Frøkjær, J. B., Brügmann, A. H., Ernst, A., Wanders, A., … Pedersen, I. S. (2023). Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital. Acta oncologica (Stockholm, Sweden), 62(3), 261–271. PMID:36905645

  • Terp, S. K., Stoico, M. P., Dybkær, K., & Pedersen, I. S. (2023). Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clinical epigenetics, 15(1), 24. PMID:36788585

  • Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, B. E., Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, J., Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B., & Lassen, U. (2023). ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial. BMC cancer, 23(1), 182. PMID:36814246

  • Schmidt, L., Issa, I. I., Haraldsdóttir, H., Hald, J. L., Schmitz, A., Due, H., & Dybkær, K. (2022). Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Cancer chemotherapy and pharmacology, 89(4), 431–440. PMID:35190872

Nyheder

Se alle nyheder

Tillykke til Issa Ismail Issa med et vellykket ph.d.-forsvar!

Fra alle medlemmer af forskningsKUBEN REPAIR, skal der lyde et stort tillykke til Issa Ismail Issa, som fredag d. 17. maj med succes forsvarede sin ph.d. 

Læs mere

FLOT STØTTE FRA NOVO NORDISK OG KRÆFTENS BEKÆMPELSE

Karen Dybkær, professor på Hæmatologisk Afdeling på Aalborg Universitetshospital, står i spidsen for to nye projekter, som skal undersøge genetiske variationer i en bestemt gruppe gener, der er relateret til reparation af DNA-skader i lymfeknudekræft. 

Læs mere

Ny artikel - Homologous Recombination Deficiency Detection Algorithms, A Systematic Review

Simone Karlsson Terp skriver således om artiklen: "Our systematic review on Homologous Recombination Deficiency (HRD) Detection Algorithms has just been published! 📑 HRD, arising from genomic mutations or alterations in the homologous recombination repair pathway, holds significance in tumor treatment, especially in PARP inhibitor sensitivity. Our systematic review analyzed 27 articles, comparing tests for HRD detection based on diverse definitions, biomarkers, and algorithms The challenge? No established gold standard HRD test due to the lack of consensus on its definition. This review sheds light on the available tests, emphasizing the need for a standard definition crucial for accurate HRD classification."

Læs mere

Opdateret